title: Measles vaccination coverage and seroprevalence of anti-measles antibody in south-east Islamic Republic of Iran.
abstract: Discrepancies often exist between recorded immunization coverage and the real immunity level in a community. To estimate the vaccination coverage against measles in south-east Islamic Republic of Iran, a crosssectional study was conducted in 3 districts during summer 2011. Using probability proportional to size cluster sampling, 1368 children aged 30-54 months were selected. Serum samples of 663 who had received 2 injections of mumpsmeasles- rubella (MMR) vaccine were checked for anti-measles IgG. Vaccination coverage for the second dose of MMR vaccine was 93.7%. The prevalence of anti-measles IgG in those who had received at least 2 MMR vaccine doses was 94.6%. There was a statistically significant association between the serological results and variables that reflected poor accessibility to health services. Combining serological results with coverage data, the proportion of the community protected against measles was estimated as 88.6%, which was below the limits defined for the measles elimination goals.
authors.affiliation: Department of Epidemiology, Health Promotion Research Centre, School of Public Health, Zahedan University of Medical Sciences, Zahedan, Islamic Republic of Iran.
authors.forename: S
authors.initials: S
authors.lastname: Izadi
authors.affiliation: Professor of Virology, National Reference Laboratory for Measles and Rubella, School of Public Health, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.
authors.forename: T
authors.initials: T
authors.lastname: Mokhtari-Azad
authors.affiliation: Centre for Communicable Disease Control, Ministry of Health and Medical Education, Tehran, Islamic Republic of Iran.
authors.forename: S M
authors.initials: SM
authors.lastname: Zahraei
mesh_terms: D000914:Antibodies, Viral / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D002675:Child, Preschool; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007223:Infant; D007492:Iran / Q000453:epidemiology; D008297:Male; D008457:Measles / Q000453:epidemiology* / Q000517:prevention & control*; D008458:Measles Vaccine; D008459:Measles virus / Q000276:immunology*; D016036:Seroepidemiologic Studies; D011795:Surveys and Questionnaires
chemical_list: D000914:Antibodies, Viral; D015415:Biomarkers; D008458:Measles Vaccine